pyrvinium has been researched along with xav939 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cashman, JR; Kalisiak, J; Lanier, M; Mercola, M; Schade, D; Spiering, S; Tsuda, M; Willems, E | 1 |
| Ai, Y; Guo, D; Li, Y; Obianom, ON; Sakamuru, S; Shu, Y; Xia, M; Xue, F; Yang, H; Yang, W | 2 |
3 other study(ies) available for pyrvinium and xav939
| Article | Year |
|---|---|
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.
Topics: Cell Differentiation; Cell Line; Embryonic Stem Cells; Heterocyclic Compounds, 3-Ring; Humans; Myocytes, Cardiac; Structure-Activity Relationship; Tetrahydronaphthalenes; Wnt Proteins | 2012 |
Triazole-Based Inhibitors of the Wnt/β-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice.
Topics: Animals; beta Catenin; Diet, High-Fat; Glucose; Glucose Tolerance Test; HEK293 Cells; Hepatocytes; Humans; Lipid Metabolism; Lithium Chloride; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Structure-Activity Relationship; Triazoles; Wnt Signaling Pathway | 2019 |
Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Proliferation; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Phosphorylation; Pyrazoles; Tumor Cells, Cultured; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2019 |